Detalles de la búsqueda
1.
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.
Genet Med
; 19(4): 430-438, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27657681
2.
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
J Pharmacol Exp Ther
; 332(1): 190-201, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19828876
3.
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.
Bioorg Med Chem Lett
; 19(19): 5552-5, 2009 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19720528
4.
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
J Pharmacol Exp Ther
; 327(3): 827-39, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18753411
5.
State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agents.
J Biomol Screen
; 11(1): 29-39, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16234337
6.
Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.
Biochem Pharmacol
; 72(6): 770-82, 2006 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-16844100
7.
Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators.
J Biomol Screen
; 10(4): 365-73, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15964938
Resultados
1 -
7
de 7
1
Próxima >
>>